Clinical Trial Update: Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pemetrexed as salvage therapy for squamous cell carcinoma of the head and neck; current status is unknown in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of Head and Neck

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: Fudan University | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 2 | Status: UNKNOWN